Antiangiogenic effect of metronomic paclitaxel treatment in prostate cancer and non-tumor tissue in the same animals: a quantitative study.
about
Immunomodulatory effects of low dose chemotherapy and perspectives of its combination with immunotherapyAn ex vivo model for anti-angiogenic drug testing on intact microvascular networksA phase 2 pilot trial of low-dose, continuous infusion, or "metronomic" paclitaxel and oral celecoxib in patients with metastatic melanomaEpisensitization: Defying Time's ArrowLow-molecular-weight heparins and angiogenesis.The pharmacological bases of the antiangiogenic activity of paclitaxel.Enhanced antitumor activity of low-dose continuous administration schedules of topotecan in prostate cancer.Antiangiogenic and antitumor activity of LP-261, a novel oral tubulin binding agent, alone and in combination with bevacizumab.Low-dose metronomic paclitaxel chemotherapy suppresses breast tumors and metastases in mice.Adjuvant taxanes and the development of breast cancer-related arm lymphoedema.Dalteparin, a low-molecular-weight heparin, promotes angiogenesis mediated by heparin-binding VEGF-A in vivo.Low-dosage metronomic chemotherapy and angiogenesis: topoisomerase inhibitors irinotecan and mitoxantrone stimulate VEGF-A-mediated angiogenesis.Low-dose continuous 5-fluorouracil infusion stimulates VEGF-A-mediated angiogenesis.An Ex Vivo Tissue Culture Model for Anti-angiogenic Drug Testing.
P2860
Q27027093-25864CA4-3443-45B4-AF90-B37A08DDFEC3Q28543862-C7A0274C-37FD-4A76-BA85-F4BBD836AF95Q33759537-85A135E9-D65C-4C43-A354-8BFD1926C2D9Q35726218-3A3CAA08-3AEE-4D4D-8F28-E0BB13A2E476Q36414904-31EC5FE9-305C-4733-BB9D-51722A3EE1C8Q36927558-F742D974-FF87-4FD5-8FCD-AB0F3D2555C5Q39516898-CFEC83D3-88BF-49D4-9664-2906F5F489B8Q39658897-6904C4A6-4CD4-4D1F-9CB9-BFEF3032C868Q39765023-24E58C61-F5B7-4FEB-9BE9-F7FE32532CDAQ40872781-4373FA91-4DC9-49F9-B0F7-7879CB57E9ADQ41212817-D6D726F1-52BC-4040-9073-28324A3C43B2Q42554491-E4C538AF-21A1-4E99-8EC8-DE743FBA27E6Q46308860-3E4247D0-C592-4C00-998B-5B6EDB94A511Q50546871-55209EF4-D382-474F-9D6E-1C2AF421F303
P2860
Antiangiogenic effect of metronomic paclitaxel treatment in prostate cancer and non-tumor tissue in the same animals: a quantitative study.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Antiangiogenic effect of metro ...... animals: a quantitative study.
@en
Antiangiogenic effect of metro ...... animals: a quantitative study.
@nl
type
label
Antiangiogenic effect of metro ...... animals: a quantitative study.
@en
Antiangiogenic effect of metro ...... animals: a quantitative study.
@nl
prefLabel
Antiangiogenic effect of metro ...... animals: a quantitative study.
@en
Antiangiogenic effect of metro ...... animals: a quantitative study.
@nl
P2093
P2860
P1476
Antiangiogenic effect of metro ...... animals: a quantitative study.
@en
P2093
Bo Lennernäs
Jan-Erik Damber
Klas Norrby
P2860
P304
P356
10.1111/J.1600-0463.2004.APM1120306.X
P577
2004-03-01T00:00:00Z